The chemotactic deactivation of human monocytes was studied to provide insight into the mechanism of chemotaxis. Deactivation was dependent on the dose of chemoattractant and time of incubation. A concentration in the cell suspension of 10' M N-formylmethionylleucyl phenylalanine (FMLP) for 45 min at 370C led to 60% suppression of the subsequent specific chemotactic response. Higher concentrations of FMLP led to almost 100% specific suppression. Deactivation was specific under all conditions used. The response to a nonrelated chemoattractant, human serum-derived C5a, was unaffected by incubation in FMLP. Deactivation was also transient. If cells were deactivated at 370C with FMLP, they recovered within 6 h at 370C from this deactivation. Both phenomena, deactivation and recovery from deactivation, were temperature dependent.
The chemotactic deactivation of human monocytes was studied to provide insight into the mechanism of chemotaxis. Deactivation was dependent on the dose of chemoattractant and time of incubation. A concentration in the cell suspension of 10' M N-formylmethionylleucyl phenylalanine (FMLP) for 45 min at 370C led to 60% suppression of the subsequent specific chemotactic response. Higher concentrations of FMLP led to almost 100% specific suppression. Deactivation was specific under all conditions used. The response to a nonrelated chemoattractant, human serum-derived C5a, was unaffected by incubation in FMLP. Deactivation was also transient. If cells were deactivated at 370C with FMLP, they recovered within 6 h at 370C from this deactivation. Both phenomena, deactivation and recovery from deactivation, were temperature dependent.
Monocytes could not be deactivated at 00C, and they did not recover from deactivation when kept at 00C. Thus, specific deactivation appears to require cellular metabolism, involving loss of receptors or blocking of a step between receptor occupancy and response.
Chemotactic deactivation refers to attractantinduced loss of migratory function, which is tested by reexposure of cells to chemotactic factor (19) . Deactivation has been described for rabbit peritoneal polymorphonuclear leukocytes (20) , human peripheral blood neutrophils (4, 9, 11, (12) (13) (14) , and eosinophils (21) . Human peripheral blood monocytes are also subject to deactivation (6, 8) . Deactivation of human peripheral neutrophils has been dissociated into two different components. Low concentrations of chemotactic factor lead to inhibition of chemotactic response that is specific for the attractant, whereas high concentrations result in inhibition of the migratory system in a nonspecific manner. Several possible mechanisms have been proposed to explain these phenomena. Loss of an esterase activity (20) or damage to the cell by production of oxidative intermediates (13) or release of lysosomal enzymes (2) has been suggested for the mechanism of deactivation. Recently, specific deactivation ofhuman peripheral blood neutrophils has been shown to correlate with loss of specific cell surface receptors for the attractant (16, 17) . In this report, we show the dynamics of deactivation of human peripheral blood monocytes. Only specific deactivation was observed even when high concentrations of attractant or relatively long incubation times were used. We also show that, in contrast to human neutrophils, human monocytes are able to recover from deactivation.
MATERIALS AND METHODS
Cell preparation. Blood was drawn from healthy donors and heparinized. Mononuclear cells were isolated by the method of Boyum (3) . Blood was diluted with an equal volume of Dulbecco phosphate-buffered saline without calcium or magnesium, and 35 ml of diluted blood was underlaid with 15 ml of Ficoll-Paque (Pharmacia Fine Chemicals, Inc., Piscataway, NJ.). After centrifugation at 400 x g for 40 min at 20°C, the interface cell layer was removed and washed twice with Gey balanced salt solution containing 2% bovine serum albumin (Cohn fraction V) (Gey-BSA; National Institutes of Health Media Unit, Bethesda, Md.). The cell suspension contained 15 to 35% monocytes, 65 to 85% lymphocytes, and less than 1% granulocytes. Viability was better than 99%, as measured by trypan blue dye exclusion. Total and differential counts were made for the final washed preparations. Total leukocyte recovery was 1 x 106 to 3 x 10' cells per ml of whole blood. Differential counts were made after staining cell suspensions with euchrysin 3RX (Roboz Surgical Instruments Co., Washington, D.C.) and observing them with a fluorescence microscope. These numbers were used to standardize the cell number added per well.
Chemotactic factors. N-Formylmethionylleucyl phenylalanine (FMLP) was purchased from Sigma Chemical Co., St. Louis, Mo. Stock solutions (10-3 M) were prepared in either ethanol or dimethyl sulfoxide and stored at -20°C. Human serum-derived complement component C5a was prepared by a modified procedure of Fernandez and Hugli (7) as described previously (6) . Briefly, fresh serum was incubated with zymosan (Mann Research Laboratory) in the presence of E-aminocaproic acid (Sigma Chemical Co.). C5a was then purified by consecutive chromatography on CM Sepharose Cl 6B (Pharmacia Fine Chemicals Inc.) and Sephadex G-100. The final preparation was stored as a solution in phosphate-buffered saline at -20°C.
Deactivation procedure. Cell preparations were diluted to concentrations of 1 x 105 to 2 x 105 monocytes per ml of Gey-BSA in 50-ml polypropylene tubes (no. 25335; Corning Glass Works, Corning, N.Y.). FMLP stock solution was diluted in Gey-BSA so that it could be diluted 1:100 into the cell suspensions. Standard incubation time for deactivation was 45 min unless indicated otherwise. After incubation, the cells were washed twice in medium at room temperature, and total and differential counts were made for the final suspensions.
For recovery experiments, the protocol was slightly changed. Cells to be tested for recovery at 0°C were put in ice immediately after deactivation, washed with cold medium, and centrifuged in the cold. Cells for testing at 37°C were washed and centrifuged at room temperature and then incubated at 37°C.
For time courses of deactivation and recovery from deactivation, cells were kept at the concentrations used for deactivation and tubes were frequently shaken. At the indicated times, samples were removed from the tubes and cells were centrifuged at 200 x g. Pellets were then suspended in Gey-BSA in 1/10 of the original sample volume. This suspension usually contained 1 x 106 to 2 x 106 monocytes per ml and was used for the chemotaxis assay.
Control cell suspensions were subjected to the identical protocol, but no FMLP was added for deactivation.
Chemotaxis assay. Chemotaxis was assayed in a multiwell chamber as described previously (5) . Bottom wells were filled with 25 pl of attractant solutions in Gey-BSA. A Nuclepore filter sheet (Neuroprobe Inc., Bethesda, Md.; Polyvinylpyrrolidone coated, 10 tim thick, 5-,um hole size) was placed over the wells. Gasket and top plate were assembled, and 50 pl of cell suspension containing 50,000 to 100,000 monocytes, depending on the experiment, was added to each top well. Chambers were incubated in moist air containing 5% carbon dioxide for 90 min. After incubation, chambers were disassembled and filters were removed. Cells remaining on the top side were wiped off; filters were immersed in methanol for 15 (Fig. 3) ofd artalP MFMLP as attractant. Cells deactivated at 0°C were wd partial washed twice at the indicated times, and the chemovarmed to tactic response to FMLP (10-7, 10-8, and 10-9 M) and ,se expern-to a 1:500 dilution of C5a was measured. The control s a metab-for each data point is the response of cells incubated it the sur-in medium for the indicated deactivation time. (1, 16) .
The deactivation of monocytes was always specific. In all experiments, we used the response to an unrelated attractant, C5a, as a control for specificity and functional capacity of the cell.
Even at very long incubation times or at concentrations of attractant that were 100-fold higher than the concentration required for 90% deactivation, nonspecific deactivation was not observed. We have shown in a previous report (6) that this is also true for other attractants used for deactivation. This is in sharp contrast to the behavior of polymorphonuclear cells from rabbits and humans (12) (13) (14) . Polymorphonuclear cell deactivation has been reported to have a specific and a nonspecific component, depending on the concentration of chemotatic factor used for deactivation. Only 40 to 50% deactivation could be achieved, and specific and nonspecific components could not be clearly separated. The nonspecific event leading to decreased cell motility was ascribed to several factors, such as (i) depletion of an enzyme or proenzyme pool or (ii) damage of the cell caused by oxidative intermediates. These mechanisms do not seem to operate in monocytes; if they do, the capacity of the cell for movement is not affected. Production of oxidative intermediates in monocytes has been shown to be poor compared with neutrophils (10, 15) , and measured oxygen uptake by monocytes upon stimulation with FMLP is also very small (data not shown). Deactivation of monocytes for a specific attractant with retention of responsiveness to other attractants suggests that deactivation is at the level of the attractant receptor or at some point in the path leading to directional movement before the common pathway activated by all attractants. Since deactivation did not occur at 00C, but required a metabolizing cell, binding to receptors by attractant appears to be insufficient for deactivation. Binding studies with labeled FMLP showed that the peptide was specifically bound at 0°C. The amount bound within 30 min of incubation was 70% of the amount bound at 220C (W. Falk, L. Harvath, and E. J. Leonard, manuscript in preparation).
It has been reported for neutrophils and human monocytes (17; J. J. Muscato, J. E. Niedel, and J. B. Weinberg, Blood 54:89a, 1979) that incubation with chemotactic factor is followed by aggregation and internalization of the receptor-attractant complex. This is an energy-dependent phenomenon and is inhibited by low temperatures. This finding provides a plausible mechanism for specific deactivation in that it leads to depletion of the cells of receptors for that specific attractant. Into that scheme fits our observation that monocytes recovered from specific deactivation within about 6 h. The recovery was inhibited by low temperature. This time period correlates with the time monocytes need to recover from depletion of immunoglobulin G receptors (18) , which has been shown to be approximately 6 
